Medically supervised weight loss in Dallas: the complete guide

Medically supervised weight loss in Highland Park, Dallas is not a prescription you buy — it is a program you enter, with a clinical evaluation, baseline labs, physician oversight, and monthly monitoring. This is the complete guide: what supervision actually means, how a GLP-1 program is structured, what to realistically expect, what it costs, and how it fits alongside the rest of the work we do at Privé.

There has never been more written about weight-loss medication, and there has rarely been so much confusion. Patients arrive at our Dallas studio having read a great deal — and still unsure what a responsible program looks like, what is safe, what things cost, and whether the version being marketed to them online is the same thing a physician-led practice provides. This guide is meant to be the single, honest resource we point people to: not a sales page, but the full picture of medically supervised weight loss as we practice it.

What "medically supervised" actually means

The phrase gets used loosely, so it is worth being precise. Medically supervised weight loss means a licensed clinical team evaluates you before any treatment, prescribes under physician supervision, and continues to monitor you for as long as you are in the program. At Privé, that supervision is real and specific: a comprehensive consultation, baseline lab work, contraindication screening, and ongoing oversight by our Medical Director, Dr. Gregory Gardner, DO, with monthly check-ins to track your response and adjust the plan.

Contrast that with the model most people have encountered: an online questionnaire, a credit-card field, and medication in the mail within days — no exam, no labs, no follow-up, no one who knows your history. The medication may look similar on paper, but the two experiences are not the same product. What you are paying for in a supervised program is precisely the part the online route removes: the evaluation that decides whether treatment is appropriate for you at all, and the monitoring that catches problems early.

This matters more with GLP-1 receptor agonists than with almost any other elective treatment, because the medication has real contraindications and a real side-effect profile. Skipping the screening is not a shortcut; it is the removal of the safeguard. When we say medically supervised weight loss in Highland Park, we mean the safeguards are the point — not an upsell layered on top of a product.

The two molecules, at a category level

Privé's weight-loss program is built around two compounded peptide medications. We describe them by mechanism rather than by comparison to any branded product, because that is the honest and clinically useful way to understand them.

Compounded semaglutide is a GLP-1 receptor agonist. It works with one of the body's own appetite- and glucose-regulating pathways: it slows gastric emptying so food produces longer-lasting fullness, moderates post-meal glucose, and signals appetite-regulation centers in the brain to reduce hunger between meals. It is compounded at a U.S. licensed, FDA-registered pharmacy and prescribed under physician supervision.

Compounded tirzepatide is a dual incretin-receptor agonist — it activates the GLP-1 receptor and, in addition, the GIP receptor (glucose-dependent insulinotropic polypeptide). That second pathway is what distinguishes it from a GLP-1-only molecule, and it can produce a different appetite and metabolic response in some patients. It, too, is compounded at a U.S. licensed, FDA-registered pharmacy and prescribed under physician supervision.

Which molecule is right for a given person is a clinical question, decided at consultation on the basis of medical history, tolerance, prior response, and goals — not a matter of picking the more expensive option or the one a friend used. For a deeper side-by-side on how these two mechanisms differ in practice, we wrote a dedicated piece: compounded semaglutide versus compounded tirzepatide.

How a program is structured

A medically supervised program is organized as a monthly relationship, not a single transaction. It moves through recognizable phases.

Consultation and baseline. Everything starts with a comprehensive consultation: medical history, current medications, goals, and contraindication screening. Baseline lab work is drawn — typically a complete metabolic panel, lipid panel, A1C, thyroid function, and any additional tests your history indicates. Labs are included in the first month. Only after the consultation and results does Dr. Gardner write the initial prescription.

Titration. Dosing begins low and increases at the pace your body tolerates, not on a fixed calendar. This deliberate ramp is how the common early side effects are minimized. If a dose is not well tolerated, we hold or step down rather than push through.

Monthly check-ins. Each month, the clinical team reviews your response, side effects, and biometric trends, and adjusts as needed. This is the supervision doing its job — it is also where questions get answered and the plan stays tailored to you.

Maintenance. Once an effective, well-tolerated dose is established, the program continues with ongoing prescriptions and monitoring, with labs repeated as clinically indicated. Duration varies by individual and goal, which we return to below.

Realistic expectations — and why we don't promise numbers

Here is where we differ most sharply from a lot of what is marketed. We do not promise a specific figure, and we do not quote study statistics as if they were your outcome. Results vary by individual. A supervised program is designed for meaningful, sustainable weight reduction that is monitored over time, not for a dramatic short-term result.

The honest reason is clinical: your outcome depends on your starting point, how your body responds to titration, your physiology, and lifestyle factors that carry real weight — diet quality, protein intake, sleep, stress, and activity. Two people on the same dose can respond quite differently. Promising a number would require us to ignore all of that, and the responsible answer is that the right expectation is an individual one we set together at consultation. What we can promise is the structure: a monitored program, a physician on call, and pharmacy provenance you can verify.

Safety, side effects, and contraindications

Treatment at Privé is prescribed only under physician supervision, after a consultation and baseline labs, and monitored with monthly check-ins — because GLP-1 receptor agonist therapy carries a real profile that deserves respect.

The most common side effect is nausea, particularly during dose titration; it is usually transient and is a large part of why we titrate slowly. Reduced appetite is the intended mechanism but can occasionally tip into unwanted suppression, which we monitor for. Gastrointestinal effects such as constipation or loose stools are also common during the ramp. Rare but serious risks include pancreatitis and gallbladder events, which is one reason ongoing supervision matters.

Certain histories are contraindications, and screening for them is non-negotiable. The program is not appropriate for anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2), a history of pancreatitis, or who is pregnant or breastfeeding. This is exactly the kind of thing an online questionnaire cannot reliably catch and a consultation is built to.

Cost transparency

Most practices will not publish weight-loss pricing. We do, because patients comparing their options deserve to do that math without making a phone call. At Privé, compounded semaglutide programs start at $350/month and compounded tirzepatide programs start at $500/month. The first month includes the consultation and baseline lab work — the evaluation is built into the price, not billed as a surprise.

Pricing "starts at" those figures because dose titration and program duration affect the total; your final pricing is confirmed at consultation. For patients who prefer to spread the cost, we accept financing through Cherry and CareCredit. Publishing this openly is deliberate: it reflects that this is a sustained monthly program, and that a practice confident in its supervision has no reason to hide what it charges.

Protecting the face during weight loss

This is the piece almost no one mentions, and it is one we care about deeply as an aesthetics practice. Meaningful weight loss can change the face. Fat is part of what gives the midface, cheeks, and temples their youthful volume, and when weight comes off — especially quickly — the face can look deflated or more drawn even as the body improves. It is sometimes noticed before anyone comments on the rest.

The answer is not to lose less; it is to plan for it. Because we treat the whole patient, we can address facial volume as part of the same conversation. Biostimulatory approaches such as Sculptra can help rebuild structural support gradually, and other volume and regenerative options — including EZGel and dermal filler — can be sequenced thoughtfully as weight stabilizes. The point is that the face is on the plan from the beginning, not an afterthought once the change has already happened. A boutique, physician-led practice is well positioned to hold both halves of that picture at once.

Integration with the rest of the practice

Weight loss rarely stands alone. Many patients layer in complementary services to support the body through the process and round out their goals.

Peptide therapy can support energy, recovery, and longevity protocols alongside a weight-loss program — our peptide menu walks through the shots and blends we offer and where each fits. IM and IV vitamin therapy provides nutritional support that matters when intake drops during active weight loss. And truSculpt body contouring is where some patients turn for cosmetic refinement of specific areas once weight has stabilized. The program is built to integrate with all of it rather than sit in a silo — and if you want the granular mechanics of the medication side, our companion guide on how the compounded tirzepatide program works goes phase by phase.

Who it's for — and who it's not

Medically supervised weight loss suits medically appropriate adults seeking sustainable weight management who can commit to a monthly cadence and are comfortable with self-administered subcutaneous injection. It fits people who want a structured, monitored program with a clinical team behind it rather than ad-hoc treatment — often patients pairing weight-loss work with broader wellness and aesthetic goals.

It is not the right fit for anyone seeking dramatic short-term results, anyone with the contraindications listed above, anyone unwilling to keep monthly check-ins, or anyone who is pregnant or breastfeeding. Being honest about who should not do this is part of doing it responsibly, and it is a conversation we would rather have at the consultation than avoid.

Why Dallas patients choose a boutique physician-supervised practice

The online model optimizes for volume and speed. A boutique practice optimizes for the opposite: knowing the patient. When you are in the Privé program, the same small clinical team sees you month over month, your history is understood rather than re-entered into a form, and the person adjusting your dose can see the whole picture — including how weight loss is affecting your face, your energy, and the rest of your goals.

That is why patients across Highland Park and greater Dallas choose supervision over a mailbox subscription. Privé is a private, RN-led studio with physician oversight, established in 2018, doing this work with restraint and transparency rather than promises. If you want a program built around your medical picture instead of a checkout flow, that is exactly what a consultation is for.